Jennifer Ku to Medicare
This is a "connection" page, showing publications Jennifer Ku has written about Medicare.
Connection Strength
1.319
-
Tolerability Outcomes of American Thoracic Society/Infectious Diseases Society of America Guideline-Recommended Multidrug Antibiotic Treatment for Mycobacterium avium Complex Pulmonary Disease in US Medicare Beneficiaries With Bronchiectasis. Chest. 2024 May; 165(5):1058-1069.
Score: 0.798
-
Evaluation of Mycobacterium Avium Complex Pulmonary Disease Treatment Completion and Adherence to ATS/IDSA Guidelines. Clin Infect Dis. 2023 02 08; 76(3):e1408-e1415.
Score: 0.188
-
Limited Validity of Diagnosis Code-based Claims to Identify Pseudomonas aeruginosa in Patients with Bronchiectasis in Medicare Data. Ann Am Thorac Soc. 2021 07; 18(7):1246-1249.
Score: 0.168
-
Validity of Diagnosis Code-Based Claims to Identify Pulmonary NTM Disease in Bronchiectasis Patients. Emerg Infect Dis. 2021 03; 27(3):982-985.
Score: 0.165